Clinical trial
REduction of Contrast Via DyeVert Used in CTO Procedures (REDUCe)
NCT03118544 is registered in ClinicalTrials.gov with Minneapolis Heart Institute Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- REduction of Contrast Via DyeVert Used in CTO Procedures (REDUCe)
- Lead sponsor
- Minneapolis Heart Institute Foundation
- Phase
- Observational
- Overall status
- Terminated
- Start date
- March 26, 2017
- Completion date
- February 2, 2018
- Enrollment
- 21 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
chronic total occlusion of coronary artery